Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
TCI Unveils Revolutionary Weight Loss Formula at SupplySide West 2023 - Human Trials Showcase Remarkable Effectiveness in Just 14 Days!
2023-10-31 15:54
iNtRON, Executes Evaluation License and Option Agreement for SAL200
2023-10-31 12:20
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC
2023-10-31 07:00
Pulsecare Medical's nsPFA clinical trial receives satisfactory short-term follow-up results
2023-10-30 23:02
AIRS Medical Accelerates Global Expansion, Showcasing clinical achievements of MRI Enhancement Solution at RSNA 2023
2023-10-30 23:00
WuXi AppTec Continued Solid Growth in the First Three Quarters of 2023 on Top of an Exceptionally Strong Year in 2022, with Profit Growth Continuously Exceeding Revenue Growth
2023-10-30 20:01
Journal of Thoracic Oncology Published Promising Results of Ivonescimab (PD-1/VEGF Bispecific) as First- or Second-line Therapy for Advanced or Metastatic Immunotherapy Naïve Non-Small-Cell Lung Cancer
2023-10-30 20:00
Foresee Pharmaceuticals to Present at the American Heart Association Annual Meeting Focusing on its ALDH2 activator FP-045 in Pulmonary Hypertension Associated with Interstitial Lung Disease
2023-10-30 15:18
Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy
2023-10-27 21:07
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India
2023-10-27 19:47
Meihua International Medical Technologies Co., Ltd.'s Subsidiary Officially Commences Construction of Comprehensive Medical Industrial Park in Hainan Free Trade Port Boao Hope City
2023-10-27 16:00
Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
2023-10-26 22:49
Lunit Participates in Saudi Vision 2030 Healthcare Sandbox, Accelerating Saudi Arabia's Healthcare Transformation
2023-10-26 21:00
Clarity and PSI kick off SAR-bisPSMA Phase III
2023-10-26 21:00
HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
2023-10-26 19:00
JINGHAO MEDICAL's self-fitting OTC hearing aids received FDA 510(k) approval
2023-10-26 17:38
Bridge Biotherapeutics Announces Positive Recommendation from the Independent Data Monitoring Committee of the BBT-877 Phase 2a Study in Idiopathic Pulmonary Fibrosis
2023-10-26 07:00
Positive results from first-in-human completely leadless CRT in the US, published in The Journal of the American College of Cardiology
2023-10-26 00:00
Neuragenex Brings Innovative Fibromyalgia Treatment to Patients Across the US
2023-10-25 23:23
Qilu Pharmaceutical announces the latest results from its clinical study on QL1706, in combination with chemotherapy, as a first-line treatment for recurrent or metastatic cervical cancer
2023-10-25 22:15
1
67
68
69
70
71
800